Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Cas No. | 2170137-61-6 (free base) |
---|---|
Purity | ≥98% |
Formula | C16H25N5 |
Formula Wt. | 287.41 |
IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
Synonym | KB0742, NSC-834161, NSC834161 |
Appearance | Yellow to brown crystal |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Non-opioid analgesic.
Iridoid glucoside found in Cornus officialis; Î...
Bisphosphonate; inhibits transfer of farnesyl p...
CB1 inverse agonist.
FGFR inhibitor.
Caffeic acid derivative.
Endogenous precursor to all steroid hormones; T...
Imidazoline derivative; α1-adrenergic agonist,...
Bisphosphonate.
ATP-sensitive K+ channel blocker, potential RyR...
PARP inhibitor; potential Pim1 inhibitor.
EGFR inhibitor.
Protease inhibitor.
Synthetic steroid hormone used in HRT; SERM, PR...
5-Fluorouracil derivative, fluorinated pyrimidi...
Iron chelator.
Fibrate; PPARα agonist.
Dihydrofolate reductase inhibitor.
Polyether Ca2+ ionophore.
Induces cardiomyogenic effects in pluripotent c...